To analyse adverse events requiring or prolonging hospitalisation in the Stent or Surgery (SoS) trial.Many adverse events following coronary revascularisation are non-major adverse cardiovascular events (non-MACE). Trials comparing percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) have reported rates of mortality and MACE only.Comparisons between PCI and CABG groups in the SOS trial were by intention to treat. For patients with non-fatal/non-MACE, number of events per 100 patient years follow-up and duration of hospital stay were assessed. Competing risk analysis was used to illustrate temporal pattern of adverse outcomes.During 2 y median follow up, 1 one or more adverse event occurred in 47.3

作者：Elved B, Roberts；Raphael, Perry；Jean, Booth；Ulrich, Sigwart；Rod H, Stables

来源：International journal of cardiology 2016 年 202卷